trade
One year on, Swiss-India trade deal favours watches over pharma
A year after the EFTA-India trade agreement took effect, Swiss watch exports are benefiting from tariff reductions while pharmaceutical companies continue to seek stronger intellectual-property protections. The piece should assess which Swiss industries are gaining and where the agreement remains contentious.
AI9 octobre 2026

Article content structure is incomplete. Please refresh or contact support.